INTLGNT BIO SOL (INBS)
(Delayed Data from NSDQ)
$1.56 USD
+0.06 (4.00%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
INBS 1.56 +0.06(4.00%)
Will INBS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for INBS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INBS
INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach
Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win
INBS: What are Zacks experts saying now?
Zacks Private Portfolio Services
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study
Other News for INBS
Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance ...
Intelligent Bio Solutions announces submission of its AI response to U.S. FDA
INBS Secures Major Contract with London Transport Operator
Intelligent Bio secures major drug testing tender with transport operator
Intelligent Bio Solutions secures drug testing tender with a London transport operator